TEVA: 梯瓦制药

TEVA新闻

• 17:31 ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs
• 15:46 3 Generic Drug Stocks to Watch as New Growth Drivers Emerge
• 13:07 Can JNJ Sustain Growth Amid Patent, Legal and China Risks?
• 14:03 AbbVie Gets EU Nod for Aquipta as Acute Treatment for Migraine
• 12:21 J&J Stock Gains Nearly 12% Year to Date: Buy, Sell or Hold Now?
• 07:15 Teva's Growth Story Is No Longer Just Generic, It's Getting Branded (NYSE:TEVA)
• 15:38 TEVA's MAA for Olanzapine LAI in Schizophrenia Accepted in the EU
• 15:22 Teva Stock Up More Than 100% in a Year: Time to Buy, Hold or Sell?
• 11:32 Novo Nordisk: Why A P/E Of 13 Is A Value Trap, Not A Bargain (NYSE:NVO)
• 12:34 Teva’s CNS Portfolio Is Growing, But Valuation Is Stretched (NYSE:TEVA)
• 15:51 Stock Market Rallies To New Highs; Apple, Google, Amazon, Sandisk, Powell In Focus: Weekly Review
• 14:18 TEVA Q1 Earnings Top Estimates, Branded Drugs Drive Revenues, Stock Up
• 15:00 Teva Pharmaceutical Industries (TEVA) Reports Q1 Earnings: What Key Metrics Have to Say
• 14:55 Israel stocks higher at close of trade; TA 35 up 1.19%
• 14:55 以色列股市上涨；截至收盘特拉维夫TA35指数上涨1.19%
• 12:58 Teva Surges 10% — And It's Not Completely Tied To Earnings
• 16:24 AMRX Valuation: What 1.69x Sales Means for Investors
• 16:23 AMRX Growth Drivers: Generics, Biosimilars, and Crexont
• 10:30 Stock Market Week Ahead: Hyperscaler Blitz, Federal Reserve Transition
• 19:02 AnaptysBio: 'Hold' As Spin-Off Shifts Pipeline To First Tracks Biotherapeutics (ANAB)
• 14:55 Israel stocks higher at close of trade; TA 35 up 0.53%
• 14:55 以色列股市上涨；截至收盘特拉维夫TA35指数上涨0.53%
• 13:12 How to Play J&J Stock Post a Beat-and-Raise Performance in Q1
• 14:42 Johnson & Johnson: Why I See Downside Ahead (NYSE:JNJ)